Orilissa (elagolix)


( Last Updated : February 18, 2020)
Generic Name:
elagolix
Project Status:
Not filed
Manufacturer:
AbbVie Corporation
Brand Name:
Orilissa
Project Line:
Reimbursement Review
Project Number:
N/A

Details


Submission Type:
Non Submission
Indications:
Moderate to severe pain associated with endometriosis
Recommendation Type:
CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer